ARCHIVES

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer

October 2, 1992

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored

November 18, 1994

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999